Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
74
TSAT Quote, Financials, Valuation and Earnings
Last price:
$26.75
Seasonality move
:
26.21%
Day range:
$25.73 - $26.87
52-week range:
$7.21 - $27.45
Dividend yield:
0%
P/E ratio:
8.58x
P/S ratio:
1.05x
P/B ratio:
0.80x
Volume:
103K
Avg. volume:
138.8K
1-year change:
199.89%
Market cap:
$394M
Revenue:
$416.6M
EPS (TTM):
-$4.45
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $612.4M | $604.8M | $583.5M | $521.5M | $416.6M | |
| Revenue Growth (YoY) | -10.78% | -1.24% | -3.51% | -10.63% | -20.12% | |
| Cost of Revenues | $24.9M | $24.1M | $41.5M | $28.5M | $27.7M | |
| Gross Profit | $587.5M | $580.7M | $542M | $493M | $388.9M | |
| Gross Profit Margin | 95.93% | 96.02% | 92.89% | 94.53% | 93.35% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $67.1M | $124.5M | $116.9M | $87.3M | $80.5M | |
| Other Inc / (Exp) | $25.6M | $6.4M | -$98.7M | $171M | -$264.4M | |
| Operating Expenses | $285.4M | $253.7M | $314.2M | $12.7M | $225M | |
| Operating Income | $302.1M | $327M | $227.9M | $480.3M | $163.9M | |
| Net Interest Expenses | $148.2M | $147.2M | $152.3M | $152.9M | $129.7M | |
| EBT. Incl. Unusual Items | $179.5M | $186.2M | -$23.2M | $498.3M | -$230.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$3.2M | $56.7M | $39.5M | $66.4M | -$9.5M | |
| Net Income to Company | $182.7M | $129.5M | -$62.7M | $432M | -$220.6M | |
| Minority Interest in Earnings | -- | -$55.7M | $44.5M | -$315.6M | $156.7M | |
| Net Income to Common Excl Extra Items | $182.7M | $73.8M | -$18.3M | $116.4M | -$64M | |
| Basic EPS (Cont. Ops) | $15.35 | $1.64 | -$1.48 | $8.67 | -$4.59 | |
| Diluted EPS (Cont. Ops) | $15.35 | $1.59 | -$1.48 | $8.36 | -$4.59 | |
| Weighted Average Basic Share | $11.9M | $45.2M | $12.3M | $13.4M | $13.9M | |
| Weighted Average Diluted Share | $11.9M | $46.6M | $12.3M | $15.3M | $13.9M | |
| EBITDA | $506.3M | $511.4M | $303.8M | $844M | $48.9M | |
| EBIT | $331.6M | $336.1M | $147.2M | $699M | -$52.2M | |
| Revenue (Reported) | $612.4M | $604.8M | $583.5M | $521.5M | $416.6M | |
| Operating Income (Reported) | $302.1M | $327M | $227.9M | $480.3M | $163.9M | |
| Operating Income (Adjusted) | $331.6M | $336.1M | $147.2M | $699M | -$52.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $150.3M | $146.6M | $135.6M | $112.8M | $81.2M | |
| Revenue Growth (YoY) | -- | -2.47% | -7.51% | -16.77% | -28.05% | |
| Cost of Revenues | $7.7M | $6.2M | $8.1M | $7.9M | $4.7M | |
| Gross Profit | $142.6M | $140.4M | $127.5M | $104.9M | $76.5M | |
| Gross Profit Margin | 94.88% | 95.78% | 94.05% | 92.97% | 94.25% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $17.5M | $34M | $22.2M | $18.8M | $18.1M | |
| Other Inc / (Exp) | $7.9M | $47M | $7.5M | -$50.7M | -$18.8M | |
| Operating Expenses | $67.7M | $86.4M | $68.2M | $56.1M | $57.8M | |
| Operating Income | $74.9M | $53.9M | $59.3M | $48.8M | $18.7M | |
| Net Interest Expenses | $33M | $37.8M | $39.5M | $32.1M | $35.1M | |
| EBT. Incl. Unusual Items | $49.8M | $63.2M | $27.3M | -$34M | -$35.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $17.2M | $15.3M | $6.3M | $4.8M | $638.4K | |
| Net Income to Company | $32.6M | $47.8M | $21M | -$38.8M | -$35.8M | |
| Minority Interest in Earnings | -- | -$36.8M | -$15.1M | $27.9M | $25M | |
| Net Income to Common Excl Extra Items | $32.6M | $11M | $5.9M | -$10.9M | -$10.8M | |
| Basic EPS (Cont. Ops) | $2.74 | $0.92 | $0.45 | -$0.80 | -$0.75 | |
| Diluted EPS (Cont. Ops) | $2.74 | $0.89 | $0.44 | -$0.80 | -$0.75 | |
| Weighted Average Basic Share | $11.9M | $12M | $13M | $13.7M | $14.4M | |
| Weighted Average Diluted Share | $11.9M | $13.6M | $14.6M | $13.7M | $14.4M | |
| EBITDA | $125.9M | $143.3M | $115.1M | $42.9M | $30M | |
| EBIT | $82.9M | $101.4M | $78.4M | $13.8M | $4.4M | |
| Revenue (Reported) | $150.3M | $146.6M | $135.6M | $112.8M | $81.2M | |
| Operating Income (Reported) | $74.9M | $53.9M | $59.3M | $48.8M | $18.7M | |
| Operating Income (Adjusted) | $82.9M | $101.4M | $78.4M | $13.8M | $4.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $601M | $571.7M | $498.8M | $385.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $22.5M | $42.6M | $28.4M | $24.4M | |
| Gross Profit | -- | $578.5M | $529.1M | $470.4M | $360.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $141.2M | $105.3M | $83.9M | $79.7M | |
| Other Inc / (Exp) | $7.9M | $46.3M | -$138.8M | $113.3M | -$224.5M | |
| Operating Expenses | -- | $261.6M | $296.1M | -$422.2K | $226.6M | |
| Operating Income | -- | $305.3M | $233M | $470.8M | $134.1M | |
| Net Interest Expenses | $33M | $151.9M | $153.8M | $145.6M | $132.5M | |
| EBT. Incl. Unusual Items | -- | $199.6M | -$59.6M | $438.5M | -$222.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $54.7M | $31.1M | $65.2M | -$12.6M | |
| Net Income to Company | -- | $144.7M | -$89.6M | $372.2M | -$217.6M | |
| Minority Interest in Earnings | -- | -$92.2M | $67M | -$273.5M | $148.5M | |
| Net Income to Common Excl Extra Items | -- | $52.7M | -$23.7M | $99.8M | -$61.8M | |
| Basic EPS (Cont. Ops) | -- | $7.47 | -$1.92 | $7.40 | -$4.35 | |
| Diluted EPS (Cont. Ops) | -- | $7.45 | -$1.98 | $7.12 | -$4.45 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | $528.9M | $274.5M | $773.2M | $44.6M | |
| EBIT | -- | $354.8M | $123M | $635.9M | -$53.1M | |
| Revenue (Reported) | -- | $601M | $571.7M | $498.8M | $385.2M | |
| Operating Income (Reported) | -- | $305.3M | $233M | $470.8M | $134.1M | |
| Operating Income (Adjusted) | -- | $354.8M | $123M | $635.9M | -$53.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $150.3M | $146.6M | $135.6M | $112.8M | $81.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $7.7M | $6.2M | $8.1M | $7.9M | $4.7M | |
| Gross Profit | $142.6M | $140.4M | $127.5M | $104.9M | $76.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $17.5M | $34M | $22.2M | $18.8M | $18.1M | |
| Other Inc / (Exp) | $7.9M | $47M | $7.5M | -$50.7M | -$18.8M | |
| Operating Expenses | $67.7M | $86.4M | $68.2M | $56.1M | $57.8M | |
| Operating Income | $74.9M | $53.9M | $59.3M | $48.8M | $18.7M | |
| Net Interest Expenses | $33M | $37.8M | $39.5M | $32.1M | $35.1M | |
| EBT. Incl. Unusual Items | $49.8M | $63.2M | $27.3M | -$34M | -$35.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $17.2M | $15.3M | $6.3M | $4.8M | $638.4K | |
| Net Income to Company | $32.6M | $47.8M | $21M | -$38.8M | -$35.8M | |
| Minority Interest in Earnings | -- | -$36.8M | -$15.1M | $27.9M | $25M | |
| Net Income to Common Excl Extra Items | $32.6M | $11M | $5.9M | -$10.9M | -$10.8M | |
| Basic EPS (Cont. Ops) | $2.74 | $0.92 | $0.45 | -$0.80 | -$0.75 | |
| Diluted EPS (Cont. Ops) | $2.74 | $0.89 | $0.44 | -$0.80 | -$0.75 | |
| Weighted Average Basic Share | $11.9M | $12M | $13M | $13.7M | $14.4M | |
| Weighted Average Diluted Share | $11.9M | $13.6M | $14.6M | $13.7M | $14.4M | |
| EBITDA | $125.9M | $143.3M | $115.1M | $42.9M | $30M | |
| EBIT | $82.9M | $101.4M | $78.4M | $13.8M | $4.4M | |
| Revenue (Reported) | $150.3M | $146.6M | $135.6M | $112.8M | $81.2M | |
| Operating Income (Reported) | $74.9M | $53.9M | $59.3M | $48.8M | $18.7M | |
| Operating Income (Adjusted) | $82.9M | $101.4M | $78.4M | $13.8M | $4.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $641.8M | $1.1B | $1.2B | $1.3B | $384.7M | |
| Short Term Investments | $351.3K | $675.3K | $379.5K | $475.7K | $393.7K | |
| Accounts Receivable, Net | $31.5M | $74.9M | $21.6M | $35.8M | $33.6M | |
| Inventory | $4.1M | $13.3M | $1.5M | $3.3M | $1M | |
| Prepaid Expenses | $4.7M | $5M | $10.6M | $5M | $4.6M | |
| Other Current Assets | $6.5M | $13.6M | $24.8M | $30.9M | $23.6M | |
| Total Current Assets | $700.8M | $1.3B | $1.3B | $1.4B | $711.6M | |
| Property Plant And Equipment | $1B | $1.1B | $1B | $950M | $1.6B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.9B | $1.9B | $1.8B | $1.8B | $1.8B | |
| Other Intangibles | $611.1M | $598.2M | $557.7M | $522.2M | $346.6M | |
| Other Long-Term Assets | $217.2K | $236.9K | $222.5K | $227.7K | $7K | |
| Total Assets | $4.4B | $5B | $4.8B | $4.8B | $4.8B | |
| Accounts Payable | $4.2M | $2.7M | $1.5M | $3.4M | $75.2M | |
| Accrued Expenses | $9.4M | $15.5M | $28.4M | $16.4M | $14.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.7M | $1.5M | $1.6M | $1.7M | $1.4M | |
| Other Current Liabilities | $20.9M | $15.3M | $10.8M | $8.7M | $6.8M | |
| Total Current Liabilities | $127.1M | $142.7M | $126.3M | $103.8M | $178.8M | |
| Long-Term Debt | $2.5B | $3B | $2.8B | $2.4B | $2.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.2B | $3.7B | $3.4B | $3B | $3.1B | |
| Common Stock | $122.1M | $33.6M | $34.3M | $38.6M | $41.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $1.1B | $326M | $354.7M | $499M | $494.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $1B | $1B | $1.3B | $1.2B | |
| Total Equity | $1.1B | $1.3B | $1.4B | $1.8B | $1.7B | |
| Total Liabilities and Equity | $4.4B | $5B | $4.8B | $4.8B | $4.8B | |
| Cash and Short Terms | $642.1M | $1.1B | $1.2B | $1.3B | $385.1M | |
| Total Debt | $2.5B | $3B | $2.8B | $2.4B | $2.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $1.2B | $1.3B | $1.3B | $557.2M | |
| Short Term Investments | -- | $685.7K | $350.4K | $493.6K | $478.7K | |
| Accounts Receivable, Net | -- | $55.1M | $38.3M | $48.3M | $43.5M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $45.5M | $45.6M | $41.1M | $185.7M | |
| Total Current Assets | -- | $1.3B | $1.4B | $1.4B | $807M | |
| Property Plant And Equipment | -- | $1.1B | $988.3M | $941.1M | $1.7B | |
| Long-Term Investments | -- | $11.2M | $7M | $4.9M | $9.1M | |
| Goodwill | -- | $2B | $1.8B | $1.8B | $1.8B | |
| Other Intangibles | -- | $608.7M | $557.2M | $512.4M | $340.5M | |
| Other Long-Term Assets | -- | $24.9M | $35M | $30.3M | $292M | |
| Total Assets | -- | $5.1B | $4.8B | $4.7B | $5B | |
| Accounts Payable | -- | $31.3M | $32.1M | $38.2M | $64.7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $3.7M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $108M | $106.9M | $80M | $73.8M | |
| Total Current Liabilities | -- | $143.5M | $142M | $120.2M | $143.2M | |
| Long-Term Debt | -- | $3B | $2.8B | $2.4B | $2.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $3.7B | $3.4B | $2.9B | $3.3B | |
| Common Stock | -- | $34.6M | $36M | $39.4M | $46.1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $1.1B | $1B | $1.3B | $1.2B | |
| Total Equity | -- | $1.4B | $1.4B | $1.8B | $1.7B | |
| Total Liabilities and Equity | -- | $5.1B | $4.8B | $4.7B | $5B | |
| Cash and Short Terms | -- | $1.2B | $1.3B | $1.3B | $557.6M | |
| Total Debt | -- | $3B | $2.8B | $2.4B | $2.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $182.7M | $129.5M | -$62.7M | $432M | -$220.6M | |
| Depreciation & Amoritzation | $174.7M | $175.3M | $156.6M | $145M | $101.1M | |
| Stock-Based Compensation | $9.3M | $58.8M | $51.8M | $24.5M | $12.8M | |
| Change in Accounts Receivable | -$3.1M | -$44.2M | $1.8M | -$18.1M | -$10.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $277.4M | $234.1M | $184.1M | $125.9M | $45.6M | |
| Capital Expenditures | $12.2M | $26.2M | $25.2M | $41.6M | $47.3M | |
| Cash Acquisitions | -- | -- | -- | -- | $2.6M | |
| Cash From Investing | -$68.8M | -$215.3M | $9M | $157M | -$796.3M | |
| Dividends Paid (Ex Special Dividend) | -$7.5K | -$8K | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $494.4M | -- | -- | -- | |
| Long-Term Debt Repaid | -$339.9M | -$1.7M | -$76.7M | -$256.4M | -$115.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $3.8M | -$10M | -$21.1M | -$7.1M | -$9M | |
| Cash From Financing | -$336M | $482.7M | -$97.8M | -$263.5M | -$124.2M | |
| Beginning Cash (CF) | $766.7M | $652.8M | $1.1B | $1.2B | $1.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$127.5M | $501.5M | $95.4M | $19.5M | -$874.9M | |
| Ending Cash (CF) | $610.8M | $1.2B | $1.3B | $1.2B | $402.7M | |
| Levered Free Cash Flow | $265.2M | $207.9M | $158.9M | $84.3M | -$1.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $32.6M | $47.8M | $21M | -$38.8M | -$35.8M | |
| Depreciation & Amoritzation | $43M | $41.8M | $36.8M | $29.1M | $25.6M | |
| Stock-Based Compensation | $1.3M | $19.1M | $6.6M | $4M | $2.3M | |
| Change in Accounts Receivable | $14.3M | -$9M | -$7.3M | $9.2M | $68.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $78.2M | $34.3M | $46.3M | $56.8M | $96.6M | |
| Capital Expenditures | $2.6M | $7.6M | $9.2M | $14.3M | $24.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$15.8M | $36.8M | -$18.4M | -$14.8M | -$160.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $236.4M | |
| Long-Term Debt Repaid | -$477.3K | -$12M | -$386.6K | -$479.7K | -$358.1K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.4M | $2.5M | -$1.1M | -$2.1M | -$4.9M | |
| Cash From Financing | -$1.8M | -$9.5M | -$1.5M | -$2.6M | $231.2M | |
| Beginning Cash (CF) | $645.7M | $1.1B | $1.2B | $1.2B | $383.9M | |
| Foreign Exchange Rate Adjustment | -$9.4M | -$11.8M | -$2.8M | $25.2M | $3.1M | |
| Additions / Reductions | $60.5M | $61.5M | $26.3M | $39.5M | $167.5M | |
| Ending Cash (CF) | $696.7M | $1.2B | $1.3B | $1.3B | $554.5M | |
| Levered Free Cash Flow | $75.5M | $26.7M | $37.1M | $42.6M | $72.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $144.7M | -$89.6M | $372.2M | -$217.6M | |
| Depreciation & Amoritzation | -- | $174.1M | $151.5M | $137.3M | $97.6M | |
| Stock-Based Compensation | $1.4M | $76.5M | $39.4M | $21.9M | $11M | |
| Change in Accounts Receivable | -- | -$67.5M | $3.5M | -$1.6M | $48.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $190.2M | $196.1M | $136.5M | $85.3M | |
| Capital Expenditures | $2.6M | $31.2M | $26.8M | $46.7M | $57.2M | |
| Cash Acquisitions | -- | -- | -- | -- | $2.6M | |
| Cash From Investing | -- | -$162.7M | -$46.2M | $160.7M | -$941.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$13.3M | -$65M | -$256.5M | -$115.4M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$6.1M | -$24.7M | -$8.1M | -$11.7M | |
| Cash From Financing | -- | $475.1M | -$89.8M | -$264.5M | $109.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $502.5M | $60.2M | $32.7M | -$746.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | $159M | $169.4M | $89.8M | $28.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $32.6M | $47.8M | $21M | -$38.8M | -$35.8M | |
| Depreciation & Amoritzation | $43M | $41.8M | $36.8M | $29.1M | $25.6M | |
| Stock-Based Compensation | $1.3M | $19.1M | $6.6M | $4M | $2.3M | |
| Change in Accounts Receivable | $14.3M | -$9M | -$7.3M | $9.2M | $68.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $78.2M | $34.3M | $46.3M | $56.8M | $96.6M | |
| Capital Expenditures | $2.6M | $7.6M | $9.2M | $14.3M | $24.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$15.8M | $36.8M | -$18.4M | -$14.8M | -$160.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $236.4M | |
| Long-Term Debt Repaid | -$477.3K | -$12M | -$386.6K | -$479.7K | -$358.1K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.4M | $2.5M | -$1.1M | -$2.1M | -$4.9M | |
| Cash From Financing | -$1.8M | -$9.5M | -$1.5M | -$2.6M | $231.2M | |
| Beginning Cash (CF) | $645.7M | $1.1B | $1.2B | $1.2B | $383.9M | |
| Foreign Exchange Rate Adjustment | -$9.4M | -$11.8M | -$2.8M | $25.2M | $3.1M | |
| Additions / Reductions | $60.5M | $61.5M | $26.3M | $39.5M | $167.5M | |
| Ending Cash (CF) | $696.7M | $1.2B | $1.3B | $1.3B | $554.5M | |
| Levered Free Cash Flow | $75.5M | $26.7M | $37.1M | $42.6M | $72.4M | |
Get TSAT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TSAT
Sector
P/E ratio
8.58x
17.70x
PEG ratio
--
0.00x
P/B ratio
0.80x
1.49x
Price / LTM sales
1.05x
0.96x
Growth Metrics
TSAT
Sector
Revenue growth
-28.05%
-0.53%
Earnings growth
-76.04%
-0.61%
Revenue (5-year growth)
-9.5%
1.59%
Earnings forecast
--
$0.05
Profitability
TSAT
Sector
Profitability FY 2024
$388.9M
$256.3M
Return on invested capital
-1.51%
0.79%
Return on assets
-1.29%
0.12%
Return on equity
-3.38%
2.1%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Aug
14
Estimated Next Earnings Date
Aug
5
Balance Sheet
TSAT
Sector
Total cash
$557.6M
$97.1M
Short term investments
$393.7K
$26.8M
Total assets
$4.8B
$827.5M
Long term debt
$2.3B
$44M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
